Company Filing History:
Years Active: 2005-2006
Title: Kirk Mykytyn: Innovator in Genetic Research
Introduction
Kirk Mykytyn is a prominent inventor based in Iowa City, IA (US), known for his significant contributions to genetic research. He has been instrumental in the identification of genes associated with Bardet Biedl Syndrome (BBS), a genetic disorder with a range of serious symptoms.
Latest Patents
Mykytyn holds two notable patents related to the genetic disease Bardet Biedl Syndrome. The first patent focuses on the identification of a gene designated BBS4, which is involved in BBS. This gene is linked to various symptoms, including obesity, diabetes, and renal cancer. The human BBS4 protein is composed of 519 amino acids and is coded by a gene that spans 16 exons. The patent also describes methods for using this gene in diagnosis, therapy, and drug screening. The second patent identifies a gene mutated at the BBS1 locus, which is the most common form of Bardet Biedl Syndrome. This gene is associated with symptoms such as hypogonadism and polydactyly. The human BBS1 protein consists of 17 exons and spans approximately 23 kb, with methods of use for diagnosis and therapy also outlined.
Career Highlights
Kirk Mykytyn is affiliated with the University of Iowa Research Foundation, where he continues to advance his research in genetics. His work has contributed to a deeper understanding of Bardet Biedl Syndrome and its underlying genetic factors.
Collaborations
Mykytyn has collaborated with notable researchers in the field, including Val C Sheffield and Edwin M Stone. These collaborations have further enhanced the impact of his research on genetic disorders.
Conclusion
Kirk Mykytyn's innovative work in identifying genes related to Bardet Biedl Syndrome has made significant strides in genetic research. His contributions continue to influence the understanding and treatment of this complex disorder.